Percutaneous Renal Denervation Should Be Considered in Hypertension Treatment

pp. 222-230

Authors

  • Cristian M. Garmendia Servicio de Hemodinamia y Cardiología Intervencionista, Hospital Italiano de Buenos Aires.
  • Carol Kotliar Directora del Laboratorio Laboratorio de Investigación Clínica & Traslacional en Envejecimiento Saludable y Cardiometabolismo; BIOMED-Conicet, Universidad Católica Argentina. Consultora del Centro de Hipertensión Arterial, Hospital Universitario Austral. Directora de Santa María de la Salud, San Isidro, Bs As. https://orcid.org/0009-0006-9871-3886

DOI:

https://doi.org/10.7775/rac.v92i3.369

Abstract

Percutaneous renal denervation: ready to be considered as an additional treatment for arterial hypertension? Two conflicting views on an intervention postulated to address cases resistant to the traditional approach. From pathophysiology to evidence from randomized clinical trials.

How to cite this article:

Garmendia CM, Kotliar C. Percutaneous Renal Denervation Should Be Considered in Hypertension Treatment? Rev Argent Cardiol 2024;92:227-35. http://dx.doi.org/10.7775/rac.v92.i3.20789

Downloads

Published

2024-07-26

Issue

Rev Argent Cardiol 2024 Vol. 92 Issue 3

Section

CONTROVERSIAS

License

Copyright (c) 2024 Argentine Journal of Cardiology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)